These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15045144)

  • 1. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations.
    Zhou W; Tsai HM
    Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.
    Kato S; Matsumoto M; Matsuyama T; Isonishi A; Hiura H; Fujimura Y
    Transfusion; 2006 Aug; 46(8):1444-52. PubMed ID: 16934083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.
    Kokame K; Matsumoto M; Fujimura Y; Miyata T
    Blood; 2004 Jan; 103(2):607-12. PubMed ID: 14512308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Tsai HM
    J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a novel ADAMTS13 activity assay for diagnosis of TMA and criteria for judgment of platelet transfusion].
    Hiura H
    Rinsho Byori; 2007 Jan; 55(1):69-75. PubMed ID: 17319494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of vWF73 and VWF114 fragments of von Willebrand factor A2 domain and their utilization in detecting ADAMTS13 activity].
    Zhang JY; Ma ZN; Dong NZ; Hu LP; Su J; Wang ZY; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):337-41. PubMed ID: 21729605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ADAMTS-13 activity in plasma using recombinant von Willebrand Factor A2 domain polypeptide as substrate.
    Cruz MA; Whitelock J; Dong JF
    Thromb Haemost; 2003 Dec; 90(6):1204-9. PubMed ID: 14652658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
    Soejima K; Nakagaki T
    Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
    Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
    Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development and application of a new ADAMTS13 assay for TTP diagnosis].
    Kokame K; Miyata T
    Rinsho Byori; 2005 Jul; 53(7):639-45. PubMed ID: 16104533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.
    Tsai HM
    Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.
    Savasan S; Lee SK; Ginsburg D; Tsai HM
    Blood; 2003 Jun; 101(11):4449-51. PubMed ID: 12576319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.
    Tsai HM
    Int J Hematol; 2002 Aug; 76 Suppl 2():132-8. PubMed ID: 12430913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The spacer domain of ADAMTS13 contains a major binding site for antibodies in patients with thrombotic thrombocytopenic purpura.
    Luken BM; Turenhout EA; Hulstein JJ; Van Mourik JA; Fijnheer R; Voorberg J
    Thromb Haemost; 2005 Feb; 93(2):267-74. PubMed ID: 15711742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on the measurement of ADAMTS13 in thrombotic thrombocytopaenic purpura.
    Pimanda JE; Chesterman CN; Hogg PJ
    Eur J Haematol; 2003 Apr; 70(4):257-62. PubMed ID: 12656756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.
    Kokame K; Miyata T
    Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.